CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

March 9, 2022 · earnings

LYRA earnings: a negative outcome, -5.3%

On March 9, 2022, Lyra Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.3% in the window around the event.

The move

$215.00
1d before
$203.50
Event day
$206.50
1d after
$202.50
5d after

Pre-catalyst setup

+3.2%
30-day run-up
8763%
30-day volatility
1.9×
volume spike